Centene Corp. stock gains 1.11 percent ahead of Q3 results

Published on 10/05/2026 at 19:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene Corp. stock trades at USD 63.69 on October 5, 2026, while Q2 adjusted EPS reached USD 2.51 versus USD 0.89 consensus. The next report is scheduled for October 27.

CGI-Architekturrender eines modernen Pharmaunternehmens-Hauptquartiers mit Glasfassade — Cencora Inc. repräsentatives Glasgebäude US15135B1017 als realistisches CGI-Architektur-Render mit Spiegelteich und Parkanlage, Illustration mit AI erstellt.

Centene Corp. stock (ISIN US15135B1017) was trading at USD 63.69 on the NYSE on October 5, 2026, up 1.11 percent from USD 62.99. The next earnings release is scheduled for October 27, giving the market a near-term test of the insurer's margin recovery.

Second quarter set the benchmark

Centene reported USD 53.579 billion in Q2 2026 revenue, compared with USD 49.944 billion in Q1 2026, a sequential increase of 7.3 percent, according to Inside-Filings.

For Q2 2026, adjusted earnings per share reached USD 2.51 against a Zacks consensus estimate of USD 0.89, producing a positive surprise of 182.02 percent, Zacks reported. The comparison matters because the upcoming Q3 estimate is USD 0.07 per share for the quarter ending September 2026.

Margin recovery meets execution risk

Centene's recovery story centers on Medicare Advantage profitability rather than member expansion. According to Investing.com on October 1, 2026, Cantor Fitzgerald said premiums were rising 33 percent while maximum out-of-pocket costs increased 10 percent.

The same report said plans covering 42 percent of affected members are exiting and that the footprint is declining 31 percent. That creates a direct tradeoff: a smaller footprint may support margins, but member retention will shape the revenue impact.

Analysts see room above the quote

The published analyst consensus is Outperform from 21 analysts, with an average price target of USD 71.78, according to MarketScreener. Against the USD 63.69 intraday price, that target lies 12.7 percent above the quote.

Cantor Fitzgerald separately reiterated an Overweight rating and a USD 75.00 price target on October 1, 2026, as margin recovery became the central investment case, Investing.com reported.

Centene stock holds a wide range

Centene stock was trading at USD 63.69 on the NYSE on October 5, 2026, at 1:27 p.m. ET. The session range was USD 62.93 to USD 64.14, while the 52-week range stood at USD 31.63 to USD 69.63.

The market capitalization was USD 31.5 billion on October 5, 2026, with volume of 1,617,223 shares at the quoted time. The October 27 earnings release will put the Q2 improvement and the 2026 outlook into the next measurable company checkpoint.